Sponsor or institution
Clinical trials and research at Chinese SLE Treatment And Research Group
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Chinese SLE Treatment And Research Group that are recruiting, in China. By phase: Phase 4 (2), Phase 1 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sirolimus added to standard therapy for adults with SLE-associated immune thrombocytopenia | Phase 2/3 | Beijing, Beijing Municipality | Recruiting | Jun 18, 2026 |
| Tracking organ damage in lupus patients | — | Beijing, Beijing Municipality | Recruiting | Mar 20, 2025 |
| Vunakizumab for mild to moderate lupus | Phase 1 | Beijing, Beijing Municipality | Recruiting | Mar 18, 2025 |
| Identifying biomarkers for lupus nephritis treatment response | — | Beijing | Recruiting | Dec 12, 2023 |
| Comparing Telitacicept with Azathioprine for ANCA-associated Vasculitis Maintenance | Phase 4 | Beijing, Beijing Municipality | Recruiting | Jul 28, 2023 |
| Combining Rituximab and Telitacicept for treating ANCA-associated Vasculitis | Phase 4 | Beijing | Recruiting | Jul 27, 2023 |
All recruiting trials (6)
-
Sirolimus added to standard therapy for adults with SLE-associated immune thrombocytopenia
This trial tests whether adding sirolimus to usual treatment helps adults with SLE-related immune thrombocytopenia see their platelet counts improve.
-
Tracking organ damage in lupus patients
This study is trying to see if tracking changes in lupus patients can help predict serious organ damage, especially in the kidneys and lungs, while they are treated with certain medications.
-
Vunakizumab for mild to moderate lupus
This trial will test whether the antibody vunakizumab helps adults with mild to moderate lupus reduce skin and joint symptoms.
-
Identifying biomarkers for lupus nephritis treatment response
This study is trying to find specific markers in blood and urine that can help predict how well people with lupus nephritis will respond to certain treatments.
-
Comparing Telitacicept with Azathioprine for ANCA-associated Vasculitis Maintenance
This study is testing if adding a new drug called Telitacicept to the standard treatment can help people with ANCA-associated vasculitis stay in remission longer.
-
Combining Rituximab and Telitacicept for treating ANCA-associated Vasculitis
This study is testing if adding Telitacicept to Rituximab treatment can help people with ANCA-associated vasculitis stay in remission longer.
Quick answers
How many clinical trials run by Chinese SLE Treatment And Research Group are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.